The capital injection aims to satisfy surging cloud demand from heavyweight clients including OpenAI, Meta, Nvidia, AMD, ...

Oracle remains a high-risk, high-potential-reward artificial intelligence stock.

Oracle announced the Oracle Life Sciences AI Data Platform, a generative AI-enabled solution designed to empower pharmaceutical, medical device, research, and life sciences organizations to accelerate ...

Oracle stock still looks like a "Buy" with an intrinsic value of $220 and AI-driven cloud growth. Here's what investors need ...

Voisin Consulting Life Sciences (VCLS), a well-established contract research organization (CRO) with a focus on unmet medical need and rare drug clinical trials, has chosen Oracle Argus to ...

Learn everything you need to know about two of the leading cloud-based infrastructure as a service providers, including how ...